Keefe, Bruyette & Woods Reiterates “Outperform” Rating for Ryan Specialty (NYSE:RYAN)

Ryan Specialty (NYSE:RYAN)‘s stock had its “outperform” rating restated by analysts at Keefe, Bruyette & Woods in a report issued on Tuesday, Benzinga reports. They presently have a $62.00 target price on the stock. Keefe, Bruyette & Woods’ price objective would suggest a potential upside of 7.92% from the company’s previous close.

Several other equities research analysts have also recently issued reports on the stock. Wolfe Research cut shares of Ryan Specialty from an “outperform” rating to a “peer perform” rating in a research note on Monday, May 6th. Wells Fargo & Company lifted their target price on shares of Ryan Specialty from $57.00 to $58.00 and gave the stock an “overweight” rating in a research note on Thursday, April 11th. JMP Securities reaffirmed a “market perform” rating on shares of Ryan Specialty in a research note on Monday, April 15th. JPMorgan Chase & Co. lifted their target price on shares of Ryan Specialty from $47.00 to $49.00 and gave the stock an “underweight” rating in a research note on Monday, April 8th. Finally, Bank of America initiated coverage on shares of Ryan Specialty in a research note on Wednesday, May 22nd. They set a “buy” rating and a $67.00 target price on the stock. One research analyst has rated the stock with a sell rating, five have issued a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Ryan Specialty currently has a consensus rating of “Hold” and a consensus target price of $55.67.

Ryan Specialty Price Performance

Ryan Specialty stock opened at $57.45 on Tuesday. The company’s fifty day moving average price is $54.38 and its 200 day moving average price is $50.13. Ryan Specialty has a 1 year low of $41.49 and a 1 year high of $61.29. The stock has a market capitalization of $14.96 billion, a P/E ratio of 108.40, a P/E/G ratio of 1.50 and a beta of 0.62. The company has a debt-to-equity ratio of 1.99, a quick ratio of 1.15 and a current ratio of 1.15.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings results on Thursday, May 2nd. The company reported $0.35 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.35. Ryan Specialty had a net margin of 9.15% and a return on equity of 45.87%. The firm had revenue of $552.00 million for the quarter, compared to analysts’ expectations of $549.06 million. During the same quarter last year, the company earned $0.26 EPS. The firm’s revenue for the quarter was up 20.6% compared to the same quarter last year. As a group, equities research analysts anticipate that Ryan Specialty will post 1.77 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. PNC Financial Services Group Inc. raised its holdings in Ryan Specialty by 192.0% in the 3rd quarter. PNC Financial Services Group Inc. now owns 549 shares of the company’s stock valued at $27,000 after buying an additional 361 shares during the period. GAMMA Investing LLC raised its holdings in Ryan Specialty by 96.4% in the 2nd quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock valued at $35,000 after buying an additional 297 shares during the period. Parkside Financial Bank & Trust raised its holdings in Ryan Specialty by 1,283.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 1,010 shares of the company’s stock valued at $43,000 after buying an additional 937 shares during the period. Intelligent Financial Strategies purchased a new stake in Ryan Specialty in the 1st quarter valued at about $44,000. Finally, Benjamin F. Edwards & Company Inc. purchased a new stake in Ryan Specialty in the 1st quarter valued at about $45,000. Hedge funds and other institutional investors own 84.82% of the company’s stock.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.